Posted by Brigham and Women's Hospital June 7, 2016
June is Men’s Health Month, a time to address important health issues that impact men’s lives. Read the stories below to learn the latest about prostate cancer, testosterone therapy, erectile dysfunction, and other factors that affect men’s physical and mental health.
A Brigham and Women’s Hospital (BWH) study has found a significant association between depression and patients being treated for localized prostate cancer with androgen deprivation therapy (ADT). When compared to patients who did not receive ADT, patients who received ADT had higher incidences of depression and inpatient and outpatient psychiatric treatment.
Testosterone use among men doesn’t appear to increase their risk of developing atherosclerosis (hardening of the arteries), a critical risk factor for heart attack and stroke. However, research also shows that men using testosterone fail to realize the quality of life benefits that are often the primary goals of testosterone therapy.
Age, high blood pressure, and cardiovascular disease contribute to a higher risk of erectile dysfunction (ED), which affects about one half of American men over age 40 at some point in their lives. Most men experiencing ED respond to nonsurgical treatments, such as oral medications or self-injection therapy. However, if these treatments don’t work, surgery may provide another option.
Research shows that men who skip breakfast have a 27 percent higher risk of suffering a heart attack or developing heart disease than those who start the day with something in their stomach. These men who forego breakfast also indulge more heavily in other unhealthy lifestyle choices, such as smoking, exercising less, and drinking alcohol regularly.
BWH-led research finds that a patient’s likelihood of getting prostate-specific antigen (PSA) testing for the early detection of prostate cancer depends on the type of physician he sees. According to the study’s lead author, the findings highlight the need for physicians to reach a broader consensus on the risks and benefits of prostate cancer screening and the importance of patients discussing their care options with their physicians.